However, this anticancer effect could be rather linked to inhibition of the “moonlighthing” or accessory functions of glycolytic enzymes which include roles in cancer development and promotion and cell cycle progression (Ganapathy-Kanniappan and Geschwind, 2013; Hu et al., 2014). The gene discussed is HK1; the disease is cancer.